Exercised-based cardiac rehabilitation associates with lower all-cause mortality in patients with primary pulmonary hypertension

BackgroundDespite pharmacological therapies to improve outcomes of pulmonary hypertension (PH), poor long-term survival remains. Exercised-based cardiac rehabilitation (ExCR) may be an alternative strategy to improve prognosis. Therefore, using an electronic medical record (EMR) database, the object...

Full description

Bibliographic Details
Published in:	Frontiers in Sports and Active Living
Main Authors:	Geert Kleinnibbelink, Benjamin J. R. Buckley, Stephanie L. Harrison, Nefyn Williams, Elnara Fazio-Eynullayeva, Paula Underhill, Arie P. J. van Dijk, Gregory Y. H. Lip, Dick H. J. Thijssen
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-12-01
Subjects:	pulmonary hypertension primary pulmonary hypertension exercise cardiac rehabilitation secondary prevention
Online Access:	https://www.frontiersin.org/articles/10.3389/fspor.2023.1247615/full

Similar Items

Exercise‐Based Cardiac Rehabilitation and All‐Cause Mortality Among Patients With Atrial Fibrillation
by: Benjamin J. R. Buckley, et al.
Published: (2021-06-01)

Atrial Fibrillation in Patients With Cardiomyopathy: Prevalence and Clinical Outcomes From Real‐World Data
by: Benjamin J. R. Buckley, et al.
Published: (2021-12-01)

Left and right ventricular strain-volume/area loops: a narrative review of current physiological understanding and potential clinical value
by: Thijs P Kerstens, et al.
Published: (2024-05-01)

Cardiovascular magnetic resonance in pulmonary hypertension
by: Bradlow William M, et al.
Published: (2012-01-01)

Rehabilitation in patients with pulmonary arterial hypertension
by: Stephan Keusch, et al.
Published: (2017-07-01)

Low nailfold capillary density in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: biomarker of clinical outcome?
by: A. J. Smits, et al.
Published: (2024-08-01)

Cardiac rehabilitation and adverse events among adult patients with simple congenital heart disease and heart failure
by: Benjamin JR Buckley, et al.
Published: (2024-06-01)

Pulmonary Arterial Hypertension: Iron Matters
by: Latha Ramakrishnan, et al.
Published: (2018-05-01)

Recent trends in pulmonary arterial hypertension
by: Rajagopalan Natarajan
Published: (2011-01-01)

Pulmonary Endarterectomy in Latvia: A National Experience
by: Matiss Sablinskis, et al.
Published: (2019-01-01)

Resolution of Severe Portopulmonary Hypertension With Inhaled Treprostinil and Liver Transplantation
by: Alex J. Chang, MD, et al.
Published: (2024-03-01)

Experimental Schistosoma haematobium pulmonary hypertension
by: Biruk Kassa, et al.
Published: (2024-01-01)

Chronic Thromboembolic Pulmonary Hypertension (CTEPH) presenting as a right atrial myxoma- A case report and review of the literature
by: Tejas Patel, et al.
Published: (2023-09-01)

Impact of residual pulmonary hypertension on long‐term outcomes after pulmonary endarterectomy in the modern era
by: Keiichi Ishida, et al.
Published: (2023-04-01)

Demographic, hemodynamic characteristics, and therapeutic trends of pulmonary hypertension patients: The Pulmonary Hypertension Mexican registry (REMEHIP)
by: Carlos Jerjes‐Sánchez, et al.
Published: (2024-04-01)

Performance of Risk‐Stratification Scores for Patients With Pulmonary Arterial Hypertension in a Multi‐Ethnic Asian Population
by: Haowen Jiang, et al.
Published: (2025-01-01)

Echocardiographic index for pulmonary hypertension discrimination in patients after pulmonary embolism - pilot study
by: M. Peneva, et al.
Published: (2024-12-01)

Optimizing Medical Pretreatment for Balloon Pulmonary Angioplasty: Overshoot or Stride Toward Optimal Multimodal Treatment
by: D. P. Staal, et al.
Published: (2025-01-01)

Progress in Pulmonary Vein Stenosis: Lessons from Success in Treating Pulmonary Arterial Hypertension
by: Kathy J. Jenkins, et al.
Published: (2022-05-01)

Introducing Historical Vignettes in Pulmonary Circulation
by: Harold I. Palevsky, et al.
Published: (2025-01-01)

Balloon Pulmonary Angioplasty for the Treatment of Chronic Thromboembolic Pulmonary Hypertension
by: Lauren N. Carlozzi, et al.
Published: (2024-05-01)

Younger age at initiation of subcutaneous treprostinil is associated with better response in pediatric Group 1 pulmonary arterial hypertension
by: Justin J. Kochanski, et al.
Published: (2024-01-01)

PULMONARY HYPERTENSION: DIFFICULT CASE IN CLINICAL PRACTICE
by: D. V. Madeeva, et al.
Published: (2014-07-01)

PULMONARY HYPERTENSION: DIFFICULT CASE IN CLINICAL PRACTICE
by: D. V. Madeeva, et al.
Published: (2014-07-01)

Inoperable chronic thromboembolic pulmonary hypertension: Evolution of prognosis over 10 years of new emerging therapies
by: Diederik P. Staal, et al.
Published: (2024-07-01)

The Epidemiology, Burden, Risk Factors, Presentations, and Challenges of Evaluating and Managing Patients with Pulmonary Hypertension in Nigeria – A Short Review
by: Oluwafemi Tunde Ojo, et al.
Published: (2024-12-01)

Pharmacogenomics in the Management of Pulmonary Arterial Hypertension: Current Perspectives
by: Coons JC, et al.
Published: (2023-07-01)

Analysis of family histories suggests shared genetic risk for chronic thromboembolic pulmonary hypertension and venous thromboembolism
by: Mark W. Dodson, et al.
Published: (2022-10-01)

The multidisciplinary management of pulmonary arterial hypertension patients in pregnancy and postpartum: A case series
by: Jasmine N. Edghill, et al.
Published: (2025-07-01)

Pulmonary arterial hypertension in the elderly: Clinical perspectives
by: Nicholas Rothbard, et al.
Published: (2020-05-01)

Disease characteristics and clinical outcome over two decades from the Swiss pulmonary hypertension registry
by: Paula Appenzeller, et al.
Published: (2022-01-01)

Efficacy and safety of tadalafil in a pediatric population with pulmonary arterial hypertension: phase 3 randomized, double‐blind placebo‐controlled study
by: Dunbar Ivy, et al.
Published: (2021-07-01)

Cardiac Arrhythmias in Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension: Mechanistic Insights, Pathophysiology, and Outcomes
by: Abdulrahman Abouzaid, et al.
Published: (2024-09-01)

Prognostic value of longitudinal vasoreactivity in pediatric pulmonary hypertension
by: Patrick D. Evers, et al.
Published: (2022-10-01)

Epoprostenol‐associated ascites in pulmonary arterial hypertension
by: Noah C. Schoenberg, et al.
Published: (2022-04-01)

Differences in Pulmonary Artery Flow Hemodynamics Between PAH and PH‐HFpEF: Insights From 4D‐Flow CMR
by: Bong‐Joon Kim, et al.
Published: (2025-01-01)

Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study)
by: Alberto M. Marra, et al.
Published: (2018-12-01)

Cellular senescence in the pathogenesis of pulmonary arterial hypertension: the good, the bad and the uncertain
by: Elmira Safaie Qamsari, et al.
Published: (2024-08-01)

Hemodynamic and gas exchange effects of inhaled iloprost in patients with COPD and pulmonary hypertension
by: Wang L, et al.
Published: (2017-11-01)

Pulmonary Hypertension Association's 2022 International Conference Scientific Sessions Overview
by: Ayedh K. Alamri, et al.
Published: (2023-01-01)